Sentence examples for genomic carrier from inspiring English sources

Key outcomes include the number of reportable carrier and additional findings, and the comparative cost, utilization, and psychosocial impacts of usual care vs. genomic carrier screening.

Through quantitative and qualitative measures, including baseline and post result disclosure surveys, post result disclosure interviews, 1 2 year follow-up interviews, and team journaling, we are obtaining data about the clinical and personal utility of genomic carrier screening in this population.

DNA samples containing predetermined concentrations and ratios of wild-type and mutated plasmids, bacterial artificial chromosomes of interest, and nonhuman genomic carrier DNA were characterized and tested in-house and in a group of nine pilot testing laboratories using a variety of technical platforms.

Linearized reporter plasmids (5 ng/µl) were co-injected with Sac1-digested sea urchin genomic carrier DNA (20 ng/µl), with or without anti-SpRunt-1 MASO m5 (600 µM).

5 ng of pEXPR-let-418p::Venus, 5 ng of pEXPR-chd-3p::DsRed25 25 ng of pRF4 and 60 ng of H. influenzae sonicated genomic carrier DNA were used to transform N2 worms by microinjection.

Using a DCE and following a rigorous methodology, Hall and colleagues [ 25] explored the factors that influenced participation in genomic carrier testing for Tay Sachs and cystic fibrosis among a sample from the general community and a sample of the Ashkenazi Jewish community.

In the present study, we investigate karyotypic variation in a single chromosome responsible for transmitting apomixis, the Apospory-Specific Genomic Region carrier chromosome, in relation to species phylogeny in the genera Pennisetum and Cenchrus.

We have discovered partial LOH events at mutated genes in tumors from the MLH1/MSH2 large genomic rearrangement carriers.

Also exemplifying the absence of marked differences in the profile of genomic changes of carriers and non-carriers of BRCA1/2 mutations, unsupervised hierarchical clustering did not stratify tumours according to their familial or sporadic condition, nor did it according to their BRCA1/2 mutation status.

MAP can reproducibly amplify single molecules to ∼200 ng product in the presence of carrier genomic DNA or RNA by an estimated four trillion-fold without nesting.

Although the real-time PCR analysis has been used previously for the detection of nucleic acids in a limited quantity of starting material, the detection of trace DNA sequences in large quantities of carrier genomic DNA has been confounded by the problems elucidated above.